A long Covid collaborative kicks off with $15M to study causes of lingering disease, conduct clinical trials

The Covid-19 pandemic has left millions of people with lingering symptoms months after initial diagnosis, and none of the handful of biopharmas that have attempted to treat the so-called long Covid have succeeded yet.

A new collaboration — bringing together researchers from leading institutes in academia — will hone in...

Click to view original post